McMaster University

McMaster University

Faculty of
Health Sciences

Hertzel Gerstein a finalist in Maclean's readers' choice poll for achievement in health care

Published: December 7 , 2006
Dr. Hertzel Gerstein is a finalist in a readers' choice poll for Achievement of the Year in Healthcare.

McMaster Professor Hertzel Gerstein is one of the finalists in the Maclean's magazine Readers' Choice Poll for Achievement of the Year in Healthcare.

Gertstein was selected as a finalist based on his role in the DREAM research project, which showed that a drug used to treat diabetes may significantly reduce the chances of developing the disease when taken by those most at risk.

Gerstein, a professor of medicine in the Michael G. DeGroote School of Medicine, was co-principal investigator on the three-year, international trial that involved 191 clinics in 21 countries.

Results of the trial showed that the drug rosiglitazone reduced the chance of getting diabetes by 60 per cent among those taking part in the trial.

The results have major implications for future health care, particularly as "baby boomers" approach the most common age for the onset of type 2 diabetes.

"If we can prevent diabetes, we may also be able to prevent the serious cardiovascular, eye, kidney, and other health consequences of diabetes," Gerstein said at the time the results were announced in September. "The DREAM results show that adding rosiglitazone to healthy lifestyle advice substantially lowers the chance of getting diabetes in people at high risk for the disease."

DREAM stands for Diabetes Reduction Assessment with ramipril and rosiglitazone medication.

Maclean’s is inviting anyone to vote online for one of four finalists in the poll. Voting closes today.
To vote in the poll go to,

Valid XHTML 1.0 Transitional Level Double-A conformance, W3C WAI Web Content Accessibility Guidelines 2.0